Incidence of congenital clubfoot in Sweden

Henrik Wallander1, Lennart Hovelius, Karl Michaelsson

  • 1Department of Orthopaedic Surgery, Gävle Hospital, Gävle, Sweden. henrik.wallander@lg.se

Acta Orthopaedica
|January 30, 2007
PubMed

Insights

The cumulative incidence of idiopathic clubfoot in Sweden is 1.4 per 1000 births, with boys affected more often. Significant regional differences were observed, warranting further investigation.

Area of Science:

  • Orthopedics
  • Pediatric Health
  • Epidemiology

Background:

  • Idiopathic clubfoot is a common congenital orthopedic condition.
  • Nationwide incidence data for clubfoot are limited.
  • This study aimed to determine the cumulative incidence in Sweden.

Purpose of the Study:

  • To prospectively assess the cumulative incidence of idiopathic clubfoot in Sweden.
  • To analyze gender distribution, regional variation, and seasonal patterns of clubfoot occurrence.

Main Methods:

  • A prospective, multicenter study was conducted over two consecutive years.
  • Data from 44 participating clinics identified new clubfoot cases.
  • Medical records of 280 children born between 1995-1996 with clubfoot were analyzed.

Main Results:

  • The average cumulative incidence of clubfoot was 1.4 per 1000 births (95% CI 1.2-1.6).
  • Boys constituted three-quarters of the cases, and half of the cases involved both feet.
  • Significant regional heterogeneity in incidence was observed, but no seasonal variation.

Conclusions:

  • The incidence of clubfoot in Sweden is higher than previously reported in Scandinavian studies.
  • Gender and laterality patterns align with prior research.
  • Significant regional differences in clubfoot incidence require further in-depth investigation.
Abstract

Related Concept Videos

Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
Development of the Limb Synovial Joints01:07

Development of the Limb Synovial Joints

Joints form during embryonic development in conjunction with the formation and growth of the associated bones. The embryonic tissue that gives rise to all bones, cartilage, and connective tissues of the body is called mesenchyme.
The mesenchymal stem cells differentiate into chondrocytes that form the hyaline cartilage, and later the cartilaginous model of the bone. This model further transforms into a bone. This process is known as endochondral ossification.
During development, the limbs...
Ankle Joint01:10

Ankle Joint

The ankle is formed by the talocrural joint (crural = leg). It consists of the articulations between the talus bone of the foot and the distal ends of the tibia and fibula of the leg. The superior aspect of the talus bone is square-shaped and has three areas of articulation. The top of the talus articulates with the inferior tibia. This is the portion of the ankle joint that carries the body weight between the leg and foot. The sides of the talus are firmly held in position by the articulations...
Sex Linked Disorders01:43

Sex Linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...